Coronary Artery Disease Clinical Trial
— ReACTOfficial title:
Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial
| Verified date | March 2017 |
| Source | Kyoto University, Graduate School of Medicine |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to evaluate the long term clinical impact of routine follow-up coronary angiography after percutaneous coronary intervention (PCI). The primary endpoint is a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure at 3-year after percutaneous coronary intervention.
| Status | Completed |
| Enrollment | 700 |
| Est. completion date | October 2016 |
| Est. primary completion date | October 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 20 Years and older |
| Eligibility |
Inclusion Criteria: - Patients received percutaneous coronary intervention - Patients older than 20 years old - Patients who will not scheduled any staged percutaneous coronary intervention |
| Country | Name | City | State |
|---|---|---|---|
| Japan | Division of Cardiology, Kyoto University Hospital | Kyoto |
| Lead Sponsor | Collaborator |
|---|---|
| Takeshi Morimoto |
Japan,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure | a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure | 4.8 years | |
| Secondary | death | death | 4.8 years | |
| Secondary | cardiac death | cardiac death | 4.8 years | |
| Secondary | myocardial infarction | myocardial infarction | 4.8 years | |
| Secondary | stent thrombosis | stent thrombosis defined bya Academic Reseach Consortium | 4.8 years | |
| Secondary | stroke | both ischemic and hemorrhagic stroke excluding transient ischemic attach | 4.8 years | |
| Secondary | bleeding complications | bleeding complications defined by GUSTO and TIMI | 4.8 years | |
| Secondary | any coronary revascularization | any coronary revascularization | 4.8 years | |
| Secondary | clinically-driven coronary revascularization | clinically-driven coronary revascularization | 4.8 years | |
| Secondary | clinically-driven target-lesion revascularization | clinically-driven target-lesion revascularization | 4.8 years | |
| Secondary | any target-lesion revascularization | any target-lesion revascularization | 4.8 years | |
| Secondary | coronary artery bypass grafting | coronary artery bypass grafting | 4.8 years | |
| Secondary | angina | angina | 4.8 years | |
| Secondary | renal function | estimate-glomerular filtration rate | 4.8 years | |
| Secondary | emergency hospitalization for acute coronary syndrome | emergency hospitalization for acute coronary syndrome | 4.8 years | |
| Secondary | hospitalization for congestive heart failure | hospitalization for congestive heart failure | 4.8 years | |
| Secondary | composite of cardiac death, myocardial infarction or acute coronary syndrome | composite of cardiac death, myocardial infarction or acute coronary syndrome | 4.8 years | |
| Secondary | follow-up coronary angiography | presence of follow-up coronary angiography | 4.8 years | |
| Secondary | clinically-driven follow-up coronary angiography | presence of clinically-driven follow-up coronary angiography | 4.8 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
| Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
| Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
| Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
| Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
| Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
| Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
| Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
| Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
| Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
| Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
| Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
| Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
| Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
| Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
| Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |